Chronic leukaemia

Drug therapies for chronic lymphocytic leukaemia (CLL)

Overview

Targeted therapy is the main treatment for chronic lymphocytic leukaemia (CLL). It uses drugs that attack specific features of leukaemia cells to stop the leukaemia growing and spreading.

Targeted therapy is sometimes used in combination with immunotherapy, which helps the immune system find and attack leukaemia cells.

Common side effects of targeted therapy is an increased risk of infection, fever and diarrhoea. Talk to your treatment team about any new side effects.

Last updated:

Targeted therapy and immunotherapy

Before the recent approval of several targeted therapies, chemotherapy (usually in combination with immunotherapy) was the main treatment for CLL. However, chemotherapy has many side effects. If you need treatment for CLL, targeted therapy (sometimes with immunotherapy) is now the usual main treatment. Targeted therapy drugs attack specific features of leukaemia cells to stop them growing and multiplying.

Targeted therapy drugs are usually given as tablets or capsules that you swallow, and can be taken at home. Targeted therapy drugs may be given alone, or in combination with immunotherapy drugs (such as rituximab or obinutuzumab). Immunotherapy drugs are usually given through a drip into a vein (intravenous infusion). This is usually during a day visit to a treatment centre.

The targeted therapy or immunotherapy drugs you are offered will depend on the stage of the CLL, the results of genetic tests, your general health, what side effects you can tolerate, and your preferences.

The main types of targeted therapy drugs are:

  • BTK inhibitors (bruton-tyrosine kinase inhibitors), including acalabrutinib, ibrutinib and zanubrutinib
  • BCL-2 inhibitors (B-cell lymphoma-2 inhibitors), including venetoclax (usually given with rituximab or obinutuzumab)
  • PI3K inhibitors (phosphoinositide 3-kinase inhibitors), including idelalisib.

If the CLL returns after initial treatment, you may be offered a different targeted therapy drug, immunotherapy or possibly chemotherapy. There is a lot of research into CLL, and new drugs are regularly becoming available. Talk to your doctor about the latest developments and if there is a suitable clinical trial you can join.

Side effects

The side effects of targeted therapy and immunotherapy drugs vary depending on the drugs given. Ask your haematologist about the specific side effects of the drugs you are taking. Some people have a reaction to the infusion – signs of this include flushing, low blood pressure, high temperature or itching. Giving the drug over several hours can help reduce reactions.

The side effects of targeted therapy may include an increased risk of infection, fever, sweating, chills and diarrhoea.

Side effects specific to certain types of targeted therapy drugs include:

  • BTK inhibitors – may cause irregular heartbeat, increased risk of bleeding and infections, high blood pressure, and headaches
  • BCL-2 inhibitors – may reduce red cells, white cells, and platelets, and may cause the release of toxic chemicals from tumour cells, which needs to be closely monitored
  • PI3K inhibitors – significantly increases the risk of serious infections.

Side effects of immunotherapy include a reaction during the injection and increased risk of infection.

If used, chemotherapy drugs can affect some of your healthy cells, which may cause a range of side effects. For example, you may bruise easily, feel very tired, feel sick (nauseous), have changes to taste and smell, or have an increased risk of infections. If you are having chemotherapy as tablets, side effects are usually mild, but the effects may be stronger if you have intravenous chemotherapy.

Your haematologist will prescribe various medicines to help ease any side effects. Some people will need a blood transfusion.

For more information, see Targeted therapy, Immunotherapy and Chemotherapy.

Taking care with infections during treatment

If your white blood cell levels drop during treatment, you are more likely to catch colds or more serious infections and need to go to hospital.

How to reduce your risk     

To prevent the spread of infections:

  • check with your doctor about having vaccines for the flu and COVID-19
  • ask people close to you to consider having vaccines for the flu and COVID-19, and if they have a contagious infection (e.g. cold, flu, COVID-19, measles, cold sore) to wait until they are well before visiting
  • as far as practical, avoid close contact with people you live with if they are unwell
  • try to avoid crowded places, such as shopping centres or public transport in peak hour
  • wash your hands with soap and water before preparing food and eating, and after using the toilet
  • prepare and store food properly to avoid foodborne illness and food poisoning
  • eat freshly cooked foods and avoid raw fish, raw seafood, raw meat, uncooked eggs and soft cheeses
  • wash fruit and vegetables well before eating.

When to seek medical help

Contact your doctor or go to the nearest hospital emergency department immediately if you experience one or more of the following symptoms:

  • a temperature of 38°C or higher
  • chills or shivering
  • sweating, especially at night
  • burning or stinging feeling when urinating
  • a severe cough or sore throat
  • shortness of breath
  • vomiting that lasts more than a few hours
  • severe abdominal pain, constipation or diarrhoea
  • unusual bleeding or bruising, such as nosebleeds, blood in your urine or black bowel motions
  • ongoing faintness or dizziness and a rapid heartbeat
  • any sudden decline in your health.

Relevant support

Leukaemia Foundation

Services offered

Cancer information Financial support and information Emotional support +3
View detail

Find support services

Find the right services for your needs, wherever you are in Australia

Read cancer information

Trusted cancer information for all people affected by cancer

Need to talk to someone?

We're available 9am - 5pm, Monday to Friday (excluding public holidays)